Monopar Therapeutics Inc’s filing revealed that its Board Member Arthur Klausner acquired Company’s shares for reported $0.34 million on Dec 18 ’25. In the deal valued at $67.16 per share,5,121 shares were bought.
Then, KLAUSNER ARTHUR J sold 5,121 shares, generating $343,889 in total proceeds. Upon selling the shares at $67.15, the Director now owns 8,762 shares.
Before that, Tactic Pharma LLC sold 550,229 shares. Monopar Therapeutics Inc shares valued at $34,999,957 were divested by the 10% Owner at a price of $63.61 per share. As a result of the transaction, Tactic Pharma LLC now holds 272,026 shares, worth roughly $18.67 million.
Raymond James downgraded its Monopar Therapeutics Inc [MNPR] rating to an Outperform from a a Strong buy in a research note published recently. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in early November with a ‘”an Outperform”‘ rating. Barclays began covering MNPR with “an Overweight” recommendation on October 13, 2025. BTIG Research started covering the stock on September 09, 2025. It rated MNPR as “a Buy”.
Price Performance Review of MNPR
On Friday, Monopar Therapeutics Inc [NASDAQ:MNPR] saw its stock jump 4.00% to $68.63. Over the last five days, the stock has lost -8.01%. Monopar Therapeutics Inc shares have risen nearly 123.70% since the year began. Nevertheless, the stocks have risen 211.95% over the past one year. While a 52-week high of $105.00 was reached on 10/06/25, a 52-week low of $21.00 was recorded on 01/03/25.
Levels Of Support And Resistance For MNPR Stock
The 24-hour chart illustrates a support level at 66.23, which if violated will result in even more drops to 63.83. On the upside, there is a resistance level at 70.57. A further resistance level may holdings at 72.51.
How much short interest is there in Monopar Therapeutics Inc?
A steep rise in short interest was recorded in Monopar Therapeutics Inc stocks on 2025-11-28, growing by 0.25 million shares to a total of 0.51 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 0.26 million shares. There was a rise of 49.4%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on September 03, 2025 when Raymond James began covering the stock and recommended ‘”a Strong buy”‘ rating along with a $80 price target.
